Keyphrases
Bronchiectasis
100%
Desmosine
78%
Chronic Obstructive Pulmonary Disease
78%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
66%
Proteomics
61%
Sputum
58%
Isodesmosine
43%
Clinical Validity
39%
Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC-MS/MS)
39%
Computational Platform
39%
Nontuberculous Mycobacterial Lung Disease
39%
Label-free Quantitative Proteomics
39%
Global View
39%
Observational Cohort Study
39%
Mycobacterium Tuberculosis (M. tb)
30%
Microbiome
29%
Virus
29%
Cystic Fibrosis
26%
Label-free
22%
Elastin Degradation
22%
Viral
19%
Neutrophil Elastase
19%
Acute Exacerbation
19%
Bronchiectasis Exacerbation
19%
Protein Profile
15%
Inflammatory Profile
14%
Sputum Samples
14%
Healthy Volunteers
13%
Label-free Shotgun Proteomics
13%
Computational Capability
13%
Computational Software
13%
Proteomic Approach
13%
Extracting Information
13%
Nontuberculous Mycobacterial Infection
13%
Benchmark Dataset
13%
Mass Spectrometry
13%
Sampling numbers
13%
Feature Detection
13%
Microbial Profile
12%
COPD Patients
9%
Viral Exacerbation
9%
Rapid PCR
9%
Total Bacterial Load
9%
Biological Mechanisms
9%
Dysregulation
9%
Elastase Activity
9%
Proteinase 3
9%
Antibiotic Treatment
9%
Heterogeneous Events
9%
Interleukin-1β
9%
Biochemistry, Genetics and Molecular Biology
Liquid Chromatography-Mass Spectrometry
88%
Desmosine
78%
Proteomics
73%
Dilution
43%
Mucin
39%
Cystic Fibrosis
39%
Quantitative Proteomics
39%
Blood Plasma
39%
Microbiome
31%
Elastin
26%
Normal Human
13%
Feature Detection
13%
Pseudomonas aeruginosa
13%
Mass Spectrometry
13%
Shotgun Proteomics
13%
16S Ribosomal RNA
7%
Proteome
7%
Bacterium Culture
7%
Dominant Inheritance
7%
Amplicon Sequencing
7%
Purple Bacteria
7%
Lung Diffusion Capacity
7%
Degranulation
7%
Peptidase
7%
Principal Component Analysis
7%
Taxon
7%
IGFBP2
6%
Immune Response
6%
Infectious Agent
6%
Iron Chelation
6%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
62%
Bronchiectasis
58%
Sputum
46%
Proteomics
41%
Silo-Filler's Disease
39%
Cystic Fibrosis
23%
Biological Marker
11%
Diseases
10%
Microbiome
10%
Infection
7%
Mycobacterial Infection
7%
Treatment Response
7%
Mucin
7%
Pseudomonas aeruginosa
7%
Endotype
5%